Aspira Capital Expenditures from 2010 to 2024

AWH Stock  USD 0.75  0.02  2.74%   
Aspira Womens' Capital Expenditures is decreasing with stable movements from year to year. Capital Expenditures is predicted to flatten to about 22.8 K. For the period between 2010 and 2024, Aspira Womens, Capital Expenditures quarterly trend regression had mean deviation of  258,256 and range of 1.2 M. View All Fundamentals
 
Capital Expenditures  
First Reported
2000-12-31
Previous Quarter
15 K
Current Value
K
Quarterly Volatility
483.7 K
 
Housing Crash
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check Aspira Womens financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Aspira Womens' main balance sheet or income statement drivers, such as Depreciation And Amortization of 189.1 K, Interest Expense of 14.5 K or Selling General Administrative of 11.5 M, as well as many indicators such as Price To Sales Ratio of 3.91, Dividend Yield of 0.0094 or Days Sales Outstanding of 73.06. Aspira financial statements analysis is a perfect complement when working with Aspira Womens Valuation or Volatility modules.
  
Check out the analysis of Aspira Womens Correlation against competitors.

Latest Aspira Womens' Capital Expenditures Growth Pattern

Below is the plot of the Capital Expenditures of Aspira Womens Health over the last few years. Capital Expenditures are funds used by Aspira Womens Health to acquire physical assets such as property, industrial buildings or equipment. This type of outlay is used by management to increase the scope of Aspira Womens operations. These expenditures can include everything from repairing an office equipment, building a brand new facility, or writing new software. It is Aspira Womens' Capital Expenditures historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Aspira Womens' overall financial position and show how it may be relating to other accounts over time.
Capital Expenditures10 Years Trend
Pretty Stable
   Capital Expenditures   
       Timeline  

Aspira Capital Expenditures Regression Statistics

Arithmetic Mean297,520
Geometric Mean146,551
Coefficient Of Variation125.64
Mean Deviation258,256
Median184,000
Standard Deviation373,815
Sample Variance139.7B
Range1.2M
R-Value(0.15)
Mean Square Error147.3B
R-Squared0.02
Significance0.60
Slope(12,201)
Total Sum of Squares2T

Aspira Capital Expenditures History

202422.8 K
202324 K
2022232 K
2021184 K
2020490 K
2019133 K
2018113 K

About Aspira Womens Financial Statements

Investors use fundamental indicators, such as Aspira Womens' Capital Expenditures, to determine how well the company is positioned to perform in the future. Although Aspira Womens' investors may analyze each financial statement separately, they are all interrelated. Understanding these patterns can help investors make the right trading decisions.
Last ReportedProjected for Next Year
Capital Expenditures24 K22.8 K

Currently Active Assets on Macroaxis

When determining whether Aspira Womens Health offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Aspira Womens' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Aspira Womens Health Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Aspira Womens Health Stock:
Check out the analysis of Aspira Womens Correlation against competitors.
You can also try the Portfolio Optimization module to compute new portfolio that will generate highest expected return given your specified tolerance for risk.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Aspira Womens. If investors know Aspira will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Aspira Womens listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(1.15)
Revenue Per Share
0.801
Quarterly Revenue Growth
(0.03)
Return On Assets
(1.86)
Return On Equity
(7.23)
The market value of Aspira Womens Health is measured differently than its book value, which is the value of Aspira that is recorded on the company's balance sheet. Investors also form their own opinion of Aspira Womens' value that differs from its market value or its book value, called intrinsic value, which is Aspira Womens' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Aspira Womens' market value can be influenced by many factors that don't directly affect Aspira Womens' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Aspira Womens' value and its price as these two are different measures arrived at by different means. Investors typically determine if Aspira Womens is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Aspira Womens' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.